Month: February 2018

Do levocetirizine and cetirizine really cause drowsiness?

I have looked at the package insert for XyzalⓇ (levocetirizine) and see no mention of drowsiness. Isn’t it that second and third generation antihistamines do not cause drowsiness or only cause drowsiness on overdose?

Levocetirizine is the levorotatory (“left-handed”) enantiomer of the second generation antihistamine cetirizine, which is a racemic mixture. Levocetirizine is sometimes referred to as a third generation antihistamine because it is a derivative of a second generation agent.

First generation antihistamines enter the brain and cause drowsiness by antihistamine actions at H1 receptors. Second generation antihistamines enter the brain less than first generation antihistamines and so cause less drowsiness. However, among the second generation antihistamines, not all are equal. Some, including cetirizine, still cause some degree of drowsiness.

Even for levocetirizine, the drowsiness is significant enough at normal clinical doses that a special precaution when driving, having high-risk work, or operating machinery is included in the product insert (see image below).  The term used for drowsiness in the package insert is somnolence.

Is dextromethorphan an opioid or not?

The Monthly Index of Medical Specialities (MIMS) states under Anatomical Therapeutic Chemical (ATC) Classification: “R05DA09 – dextromethorphan; Belongs to the class of opium alkaloids and derivatives. Used as cough suppressant”. But your lecture and the textbooks say that dextromethorphan is a non-opioid antitussive. Why is there this discrepancy?

An opium alkaloid is an alkaloid found in opium. An opioid is a drug which acts at opioid receptors. The major active alkaloids in opium, such as morphine and codeine, act at opioid receptors.  They are both opium alkaloids and opioids. But not all opium alkaloids act at opioid receptors. Dextromethorphan is chemically an opium alkaloid derivative but it does not act at opioid receptors so pharmacologically it is not an opioid. It is a non-opioid opium alkaloid derivative.

Just as codeine is metabolised to morphine, dextromethorphan is converted to the more potent active metabolite dextrorphan. Dextrorphan is a dextro- (right-handed) enantiomer (dextrorotatory-stereoisomer) of which the corresponding levo- (left-handed) enantiomer is levorphanol, a potent opioid analgesic. Dextromethorphan and dextrorphan are right-handed enantiomers that do not act at the opioid receptor. They are therefore not opioids despite being opium alkaloid derivatives closely related to the potent opioid levorphanol.

The importance of dextromethorphan being a non-opioid is that does not share the same mechanisms of opioid dependence and addiction as codeine and so has a lower potential for abuse than codeine.  However, dextromethorphan is not utterly devoid of risk of abuse. Dextromethorphan is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist and at high doses has dissociative anaesthetic-like effects similar to ketamine and phencyclidine (PCP).

© 2024 PharmaNUS

Theme by Anders NorenUp ↑

Viewing Message: 1 of 1.
Warning

Blog.nus accounts will move to SSO login, tentatively before the start of AY24/25 Sem 2. Once implemented, only current NUS staff and students will be able to log in to Blog.nus. Public blogs remain readable to non-logged in users. (More information.)

Skip to toolbar